What is the current status of domestically produced drugs venetoclax/venetoclax?

Venetoclax/Venetoclax, as a breakthrough leukemia treatment drug, currently has no domestic version launched in China. This innovative drug, jointly developed by AbbVie Pharmaceuticals and Roche Pharmaceuticals in the United States, has been widely recognized and used around the world. The two pharmaceutical giants have invested a large amount of scientific research resources and funds in the R&D and production processes to ensure the high quality and therapeutic effect of venetoclax.

As a highly efficientBCL-2 selective BH3 mimetic drug, venetoclax has been clinically proven to have significant efficacy in treating chronic lymphocytic leukemia, acute myeloid leukemia and other diseases. In addition, it also demonstrated a role in inhibiting mitochondrial metabolism, which is consistent with the regulatory function of BCL-2 in body metabolism.

For patients who need to use venetoclax, their doctor's advice, personal health status, and financial affordability should be taken into consideration when choosing this drug. Currently, the original drug of venetoclax has been launched in the domestic market and provides diversified specifications to meet the needs of different patients. The price varies depending on the specifications, and each box is priced between RMB 1,000 and RMB 4,000.

Although there is currently no domestically produced Venetoclax on the Chinese market, with the continuous advancement of medical technology and the continuous development of domestic pharmaceutical companies, domestically produced Venetoclax may also appear in the future. When purchasing and using venetoclax, patients should remain vigilant and ensure that they are purchased from regular channels to avoid counterfeit and shoddy products. At the same time, you must strictly follow the doctor's instructions and take the medication according to the prescribed medication method and dosage to prevent adverse reactions and drug interactions. During the treatment process, patients should also pay close attention to the physical reaction and drug efficacy, and communicate with the doctor for feedback in a timely manner.